메뉴 건너뛰기
Urology
Volumn 77, Issue 2, 2011, Pages 514-
Reply by the authors to a letter by Chueh et al.
Author keywords

[No Author keywords available]
Indexed keywords

IMMUNOSUPPRESSIVE AGENT;
EID: 79551592372     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.10.024     Document Type: Letter
Times cited : (1)
References (8)
  • 1
    • 77952742173 scopus 로고    scopus 로고
    • Surgical treatment of renal cell carcinoma in the immunocompromised transplant patient
    • M.K. Tollefson, A.E. Krambeck, and B.C. Leibovich Surgical treatment of renal cell carcinoma in the immunocompromised transplant patient Urology 75 2010 1373 1377
    • (2010) Urology , vol.75 , pp. 1373-1377
    • Tollefson, M.K.1    Krambeck, A.E.2    Leibovich, B.C.3
  • 2
    • 78650869231 scopus 로고    scopus 로고
    • Re: Tollefson et al.: Surgical treatment of renal cell carcinoma in the immunocompromised transplant patient
    • S.C. Chueh, S. Flechner, and D. Goldfarb Re: Tollefson et al.: Surgical treatment of renal cell carcinoma in the immunocompromised transplant patient Urology 77 2010 253 254
    • (2010) Urology , vol.77 , pp. 253-254
    • Chueh, S.C.1    Flechner, S.2    Goldfarb, D.3
  • 3
    • 33846026396 scopus 로고    scopus 로고
    • Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: The D-SSIGN score
    • R.H. Thompson, B.C. Leibovich, and C.M. Lohse Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score J Urol 177 2007 477 480
    • (2007) J Urol , vol.177 , pp. 477-480
    • Thompson, R.H.1    Leibovich, B.C.2    Lohse, C.M.3
  • 4
    • 4344578504 scopus 로고    scopus 로고
    • Use of the University of California, Los Angeles integrated staging system to predict survival in renal cell carcinoma: An international multicenter study
    • J.J. Patard, H.L. Kim, and J.S. Lam Use of the University of California, Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study J Clin Oncol 22 2004 3316 3322
    • (2004) J Clin Oncol , vol.22 , pp. 3316-3322
    • Patard, J.J.1    Kim, H.L.2    Lam, J.S.3
  • 5
    • 68049140780 scopus 로고    scopus 로고
    • Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with aldesleukin (interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients
    • T. Schwaab, A. Schwarzer, and B. Wolf Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with aldesleukin (interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients Clin Cancer Res 15 2009 4986 4992
    • (2009) Clin Cancer Res , vol.15 , pp. 4986-4992
    • Schwaab, T.1    Schwarzer, A.2    Wolf, B.3
  • 7
    • 77956227464 scopus 로고    scopus 로고
    • Phase 3 trial of everolimus for metastatic renal cell carcinoma: Final results and analysis of prognostic factors
    • RECORD-1 Study Group
    • R.J. Motzer, B. Escudier, S. Oudard RECORD-1 Study Group Phase 3 trial of everolimus for metastatic renal cell carcinoma: final results and analysis of prognostic factors Cancer 116 2010 4256 4265
    • (2010) Cancer , vol.116 , pp. 4256-4265
    • Motzer, R.J.1    Escudier, B.2    Oudard, S.3
  • 8
    • 77951729433 scopus 로고    scopus 로고
    • FDA approval summary: Temsirolimus as treatment for advanced renal cell carcinoma
    • V.E. Kwitkowski, T.M. Prowell, and A. Ibrahim FDA approval summary: temsirolimus as treatment for advanced renal cell carcinoma Oncologist 15 2010 428 435
    • (2010) Oncologist , vol.15 , pp. 428-435
    • Kwitkowski, V.E.1    Prowell, T.M.2    Ibrahim, A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.